International Publisher of Science, Technology and Medicine

 
 
Share this
 
 
 
Track Your Manuscript
 
 
 
 
Journal of Hypo & Hyperglycemia
   
Editorial Board: David Van Thiel, PhD
 Rush University Medical Center, USA  view all
ISSN: 2327-4700
Frequency: Quarterly
   

The Journal of Hypo & Hyperglycemia (JHHG) promotes rigorous research that makes a significant contribution in advancing knowledge for diabetes medication. JHHG includes all major themes pertaining to diabetes and related side effects.

Journal of Hypo & Hyperglycemia is a subscription based journal that provides a range of options to purchase our articles and also permits unlimited Internet Access to complete Journal content. It accepts research, review papers, online letters to the editors & brief comments on previously published articles or other relevant findings in SciTechnol. Articles submitted by authors are evaluated by a group of peer review experts in the field and ensures that the published articles are of high quality, reflect solid scholarship in their fields, and that the information they contain is accurate and reliable.Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

 
Manuscripts can be submitted through Online or send as an e-mail attachment to the Editorial Office at editor.jhhg@scitechnol.com or editor.jhhg@scitechnol.org
 
Journal of Hypo and Hyperglycemia is associated with our international conference"5th World Congress on Diabetes & Metabolism" (Diabetes-2014) during November 03-05, 2014 Las Vegas, USA with a theme “To Translate and Harness the Novel Therapies in Diabetes”. The major sessions include Clinical Diabetes and Diagnostic Approaches, Diabetes Management. its complications, Treatment of Diabetes, Genetics of Diabetes, Transplantation for Diabetes and many other.
 
Current Issue
Editors & Editorial Board Members  
J Hypo Hyperglycemia 2013, 1:1   
  PDF   
Longitudinal Studies of Diabetes in Environmental Epidemiology: Is Incident Diabetes the Right Outcome?   Editorial
Charles J. Everett
J Hypo Hyperglycemia 2013, 1:1    doi: 10.4172/2327-4700.1000e101
 Preview

Longitudinal Studies of Diabetes in Environmental Epidemiology: Is Incident Diabetes the Right Outcome?

While numerous cross-sectional studies have shown associations between environmental pollutants and diabetes, the results of longitudinal studies have been mixed. The question remains, why do some longitudinal studies of incident diabetes and environmental pollutants have negative results?

|  Full Text |   PDF   
The Effect of Colestimide on Visceral Fat Mass and Cytokine Levels in Patients with Metabolic Syndrome   Rapid Communication
Tatsuya Suzuki, Masao Hashimoto, Shoko Futami-Suda, Yoshimasa Igari, Kentaro Watanabe, Hiroshi Nakano, Joan Auwerx, Mitsuhiro Watanabe and Kenzo Oba
J Hypo Hyperglycemia 2013, 1:1    doi: 10.4172/2327-4700.1000101
 Preview

The Effect of Colestimide on Visceral Fat Mass and Cytokine Levels in Patients with Metabolic Syndrome

Bile acid–binding resins (BABRs) improve hyperglycemia in patients with type 2 diabetes, and the BABR colesevelam has been approved by the U.S. Food and Drug Administration for use as an antihyperglycemic agent. Colestimide (colestilan) is a new type of anion resin that increases the number of hepatic low-density lipoprotein receptors and decreases serum cholesterol levels by promoting the excretion of bile acids and inhibiting the absorption of cholesterol in the intestine; with these changes, the serum level of low-density lipoprotein cholesterol decreases.

|  Full Text |   PDF   
Vitamin D and Diabetes Mellitus: What Do We Know?   Review Article
Jian Liu
J Hypo Hyperglycemia 2013, 1:1    doi: 10.4172/2327-4700.1000102
 Preview

Vitamin D and Diabetes Mellitus: What Do We Know?

Diabetes mellitus, as a common metabolic disease, affects millions people’s health worldwide and its incidence is continuing to increase. It is important to find effective measures of prevention and/or intervention for the disease to reduce its impact on the risk for cardiovascular disease – the leading cause of mortality among patients with diabetes mellitus. Apart from its well-known “classic” effect in bone metabolism, vitamin D has received widespread attention for its potential role in the prevention of diabetes mellitus, in particular type 2 diabetes mellitus.

|  Full Text |   PDF   
Myocardial Flow Reserve Partially Recovered after Additional Intensive Anti-Hyperglycemic Therapy in Patients with Type 2 Diabetes   Research Article
Ikuo Yokoyama, Yusuke Inoue and Toshiyuki Moritan
J Hypo Hyperglycemia 2013, 1:1    doi: 10.4172/2327-4700.1000103
 Preview

Myocardial Flow Reserve Partially Recovered after Additional Intensive Anti-Hyperglycemic Therapy in Patients with Type 2 Diabetes

Impaired myocardial perfusion, such as coronary microangiopathy, is one of the important pathophysiological characteristics of diabetes  and a clinically important unresolved clinical question. The importance of glycemic control in the development of atherosclerosis in patients with diabetes has been suggested. We previously reported that myocardial flow reserve (MFR) was related to glycemic control rather than to the mode of therapy in patients with type 2 diabetes (T2DM).

|  Full Text |   PDF